High-mobility Group Box 1 (HMGB1) is a nuclear protein that plays a key role in acute and chronic inflammation. It has already been studied in several diseases, among them melanoma. Indeed, HMGB1 is closely associated with cell survival and proliferation and may be directly involved in tumor cell metastasis development thanks to its ability to promote cell migration. This research aims to assess the role of this molecule in the pathogenesis of human melanoma and its potential therapeutic role. The research has been conducted on the PubMed database, and the resulting articles are sorted by year of publication, showing an increasing interest in the last five years. The results showed that HMGB1 plays a crucial role in the pathogenesis of skin cancer, prognosis, and therapeutical response to therapy. Traditional therapies target this molecule indirectly, but future perspectives could include the development of new target therapy against HMGB1, thus adding a new approach to the therapy, which has often shown primary and secondary resistance. This could add a new therapy arm which has to be prolonged and specific for each patient.

Li Pomi F., Borgia F., Custurone P., Vaccaro M., Pioggia G., Gangemi S (2022). Role of HMGB1 in Cutaneous Melanoma: State of the Art. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(16) [10.3390/ijms23169327].

Role of HMGB1 in Cutaneous Melanoma: State of the Art

Li Pomi F.;
2022-08-01

Abstract

High-mobility Group Box 1 (HMGB1) is a nuclear protein that plays a key role in acute and chronic inflammation. It has already been studied in several diseases, among them melanoma. Indeed, HMGB1 is closely associated with cell survival and proliferation and may be directly involved in tumor cell metastasis development thanks to its ability to promote cell migration. This research aims to assess the role of this molecule in the pathogenesis of human melanoma and its potential therapeutic role. The research has been conducted on the PubMed database, and the resulting articles are sorted by year of publication, showing an increasing interest in the last five years. The results showed that HMGB1 plays a crucial role in the pathogenesis of skin cancer, prognosis, and therapeutical response to therapy. Traditional therapies target this molecule indirectly, but future perspectives could include the development of new target therapy against HMGB1, thus adding a new approach to the therapy, which has often shown primary and secondary resistance. This could add a new therapy arm which has to be prolonged and specific for each patient.
ago-2022
Li Pomi F., Borgia F., Custurone P., Vaccaro M., Pioggia G., Gangemi S (2022). Role of HMGB1 in Cutaneous Melanoma: State of the Art. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(16) [10.3390/ijms23169327].
File in questo prodotto:
File Dimensione Formato  
Role of HMGB1 in Cutaneous Melanoma: State of the Art.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 965.15 kB
Formato Adobe PDF
965.15 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/603994
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 18
social impact